• Nenhum resultado encontrado

Granulocyte Colony-Stimulating Factor Combined with Methylprednisolone Improves Functional Outcomes in Rats with Experimental Acute Spinal Cord Injury

N/A
N/A
Protected

Academic year: 2019

Share "Granulocyte Colony-Stimulating Factor Combined with Methylprednisolone Improves Functional Outcomes in Rats with Experimental Acute Spinal Cord Injury"

Copied!
8
0
0

Texto

Loading

Imagem

Table 1 - Basso, Beattie, and Bresnahan (BBB) rating scores for hindlimbs, according to the evaluation times after spinal cord injury:
Table 4 shows the results of the histological analysis.
Table 4 - Histological analysis scores according to the variables necrosis, hemorrhage, hyperemia, degeneration, and cellular infiltrate:

Referências

Documentos relacionados

Evaluation of the functional recovery of the spinal cord in spinal cord injury rats between microglial cell transplantation group A and saline injection group B.. Data are reported

Considering that protocols with stem cell transplantation and treadmill training have shown promising results, the present study evaluated the effectiveness of stem cells from

Nitric oxide metabolites in the lumbosacral spinal cord interstice and cerebrospinal fluid in female.. rats with acute

Despite the fact that co-administration of methyl- prednisolone with GM-1 during the acute phase of spinal cord injuries in rats resulted in beneficial functional outcomes, one

Early versus delayed decompression for traumatic cervical spinal cord injury: results of the Surgical Timing in Acute Spinal Cord Injury Study (STASCIS).. Letaif OB, Damasceno

METHODS: In this experimental study, 20 male Wistar rats were divided into two groups: one group with rats undergoing spinal cord injury (SCI) at T10 and receiving estrogen therapy

The PubMed database was searched for articles with the terms “spinal cord injury AND methylprednisolone/GM1/apoptosis inhibitor/calpain inhibitor/naloxone/tempol/tirilazad”,

Is it feasible to use granulocyte-colony stimulating factor alone to mobilize progenitor cells in multiple myeloma patients induced with a cyclophosphamide, thalidomide